S. Huan

Influence of mobilized peripheral blood cells on the hematopoietic recovery by autologous marrow and recombinant human granulocyte-macrophage colony-stimulating factor after high-dose cyclophosphamide, etoposide, and cisplatin.

R. Wallerstein, B. Andersson, F. Dunphy, 1992, Blood.

Impact of autologous bone marrow infusion on hematopoietic recovery after high-dose cyclophosphamide, etoposide, and cisplatin.

G. Hortobagyi, R. Wallerstein, F. Holmes, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase III study of high-dose intensification without hematopoietic progenitor cells support for patients with high-risk primary breast carcinoma.

S. Gertler, E. Tomiak, D. Stewart, 2000, American journal of clinical oncology.

Use of recombinant human hematopoietic growth factors and autologous bone marrow transplantation to attenuate the neutropenic trough of high-dose therapy.

S. Jagannath, A. Deisseroth, F. Dunphy, 1990, International journal of cell cloning.

Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation

M. Dimopoulos, S. Jagannath, J. Spinolo, 1994, American journal of hematology.

Factors predicting long‐term survival for metastatic breast cancer patients treated with high‐dose chemotherapy and bone marrow support

G. Hortobagyi, A. Buzdar, G N Hortobagyi, 1994, Cancer.

Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantation

R. Wallerstein, B. Andersson, J. Tarrand, 1991, European journal of haematology.

Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantation

R. Wallerstein, B. Andersson, J. Tarrand, 1991 .